• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PALB2 癌症易感性基因在家族性黑色素瘤中的突变分析。

Mutation analysis of the PALB2 cancer predisposition gene in familial melanoma.

机构信息

Program in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University, Montreal, QC, Canada.

出版信息

Fam Cancer. 2011 Jun;10(2):315-7. doi: 10.1007/s10689-010-9405-y.

DOI:10.1007/s10689-010-9405-y
PMID:21153565
Abstract

PALB2 is a breast and pancreas cancer susceptibility gene whose protein is closely associated with BRCA2 and is essential for BRCA2 anchorage to nuclear structures. This functional relationship made PALB2 a candidate gene for susceptibility to BRCA2-related cancers such as melanoma. The purpose of this study was to screen for the presence of germline mutations in PALB2 in familial melanoma cases. We sequenced the exons and intron-exon boundaries of PALB2 in probands from 53 families with familial melanoma where CDKN2A mutations were absent. A number of previously reported coding and non-coding variants were observed. However, no truncating mutations were identified. These results indicate that deleterious PALB2 mutations are unlikely to play a significant role in familial melanoma.

摘要

PALB2 是一种乳腺癌和胰腺癌易感基因,其蛋白与 BRCA2 密切相关,是 BRCA2 锚定核结构所必需的。这种功能关系使 PALB2 成为易患 BRCA2 相关癌症(如黑色素瘤)的候选基因。本研究旨在筛查无 CDKN2A 突变的家族性黑色素瘤病例中 PALB2 种系突变的存在。我们对 53 个家族性黑色素瘤先证者的 PALB2 外显子和内含子-外显子边界进行了测序,这些家族中缺失 CDKN2A 突变。观察到了一些先前报道的编码和非编码变异。然而,没有发现截断突变。这些结果表明,有害的 PALB2 突变不太可能在家族性黑色素瘤中发挥重要作用。

相似文献

1
Mutation analysis of the PALB2 cancer predisposition gene in familial melanoma.PALB2 癌症易感性基因在家族性黑色素瘤中的突变分析。
Fam Cancer. 2011 Jun;10(2):315-7. doi: 10.1007/s10689-010-9405-y.
2
Assessment of PALB2 as a candidate melanoma susceptibility gene.评估PALB2作为黑色素瘤候选易感基因的情况。
PLoS One. 2014 Jun 20;9(6):e100683. doi: 10.1371/journal.pone.0100683. eCollection 2014.
3
Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer.遗传性前列腺癌中与BRCA2相互作用蛋白PALB2编码基因的分析。
Prostate. 2008 May 1;68(6):675-8. doi: 10.1002/pros.20729.
4
BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.家族性胰腺癌中BRCA1、BRCA2、PALB2和CDKN2A突变:一项PACGENE研究。
Genet Med. 2015 Jul;17(7):569-77. doi: 10.1038/gim.2014.153. Epub 2014 Nov 20.
5
Novel germline PALB2 truncating mutations in African American breast cancer patients.非洲裔美国乳腺癌患者中新发种系 PALB2 截断突变。
Cancer. 2012 Mar 1;118(5):1362-70. doi: 10.1002/cncr.26388. Epub 2011 Aug 26.
6
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.PALB2编码一种与BRCA2相互作用的蛋白质,是一种乳腺癌易感基因。
Nat Genet. 2007 Feb;39(2):165-7. doi: 10.1038/ng1959. Epub 2006 Dec 31.
7
Germline mutations of PALB2 gene in a sequential series of Chinese patients with breast cancer.中国连续系列乳腺癌患者 PALB2 基因种系突变。
Breast Cancer Res Treat. 2017 Dec;166(3):865-873. doi: 10.1007/s10549-017-4425-z. Epub 2017 Aug 20.
8
Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer.CDKN2A 基因突变相关的黑色素瘤易感家系中无胚系 PALB2 突变与胰腺癌。
Fam Cancer. 2011 Sep;10(3):545-8. doi: 10.1007/s10689-011-9447-9.
9
Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families.澳大利亚多病例乳腺癌家族中PALB2突变的患病率。
Breast Cancer Res. 2013 Feb 28;15(1):R17. doi: 10.1186/bcr3392.
10
Mutation analysis of PALB2 gene in French breast cancer families.法国乳腺癌家族中PALB2基因的突变分析
Breast Cancer Res Treat. 2015 Dec;154(3):463-71. doi: 10.1007/s10549-015-3625-7. Epub 2015 Nov 12.

引用本文的文献

1
PARP Inhibitors in Melanoma-An Expanding Therapeutic Option?PARP抑制剂在黑色素瘤中的应用——一种不断扩展的治疗选择?
Cancers (Basel). 2021 Sep 8;13(18):4520. doi: 10.3390/cancers13184520.
2
Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada.加拿大安大略省东部BRCA1和BRCA2基因阴性的乳腺癌和/或卵巢癌家族中PALB2基因的突变分析。
Hered Cancer Clin Pract. 2014 Aug 28;12(1):19. doi: 10.1186/1897-4287-12-19. eCollection 2014.
3
Assessment of PALB2 as a candidate melanoma susceptibility gene.

本文引用的文献

1
PALB2/FANCN: recombining cancer and Fanconi anemia.PALB2/FANCN:重组癌症与范可尼贫血。
Cancer Res. 2010 Oct 1;70(19):7353-9. doi: 10.1158/0008-5472.CAN-10-1012. Epub 2010 Sep 21.
2
BRCA1 and BRCA2 families and the risk of skin cancer.BRCA1 和 BRCA2 家族与皮肤癌风险。
Fam Cancer. 2010 Dec;9(4):489-93. doi: 10.1007/s10689-010-9377-y.
3
Genetic risk factors for melanoma.黑色素瘤的遗传风险因素。
评估PALB2作为黑色素瘤候选易感基因的情况。
PLoS One. 2014 Jun 20;9(6):e100683. doi: 10.1371/journal.pone.0100683. eCollection 2014.
4
Analysis of the miR-34a locus in 62 patients with familial cutaneous melanoma negative for CDKN2A/CDK4 screening.分析 62 例 CDKN2A/CDK4 筛查阴性的家族性皮肤黑素瘤患者的 miR-34a 基因座。
Fam Cancer. 2012 Jun;11(2):201-8. doi: 10.1007/s10689-011-9502-6.
5
Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer.CDKN2A 基因突变相关的黑色素瘤易感家系中无胚系 PALB2 突变与胰腺癌。
Fam Cancer. 2011 Sep;10(3):545-8. doi: 10.1007/s10689-011-9447-9.
Hum Genet. 2009 Oct;126(4):499-510. doi: 10.1007/s00439-009-0715-9. Epub 2009 Jul 8.
4
Analysis of PALB2/FANCN-associated breast cancer families.与PALB2/FANCN相关的乳腺癌家族分析。
Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6788-93. doi: 10.1073/pnas.0701724104. Epub 2007 Apr 9.
5
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.PALB2编码一种与BRCA2相互作用的蛋白质,是一种乳腺癌易感基因。
Nat Genet. 2007 Feb;39(2):165-7. doi: 10.1038/ng1959. Epub 2006 Dec 31.
6
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.跨GenoMEL研究的高危黑色素瘤易感基因与胰腺癌、神经系统肿瘤及葡萄膜黑色素瘤
Cancer Res. 2006 Oct 15;66(20):9818-28. doi: 10.1158/0008-5472.CAN-06-0494.
7
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.核伴侣蛋白PALB2对BRCA2细胞功能和临床功能的调控
Mol Cell. 2006 Jun 23;22(6):719-729. doi: 10.1016/j.molcel.2006.05.022.
8
BRCA1 and BRCA2: 1994 and beyond.乳腺癌1号基因(BRCA1)和乳腺癌2号基因(BRCA2):1994年及以后
Nat Rev Cancer. 2004 Sep;4(9):665-76. doi: 10.1038/nrc1431.
9
Cancer risks in BRCA2 mutation carriers.携带BRCA2基因突变者的癌症风险。
J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6. doi: 10.1093/jnci/91.15.1310.
10
Germline p16 mutations in familial melanoma.家族性黑色素瘤中的种系p16突变
Nat Genet. 1994 Sep;8(1):15-21. doi: 10.1038/ng0994-15.